<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dale J</submitter><funding>Pfizer UK</funding><funding>Chief Scientist Office</funding><pagination>461</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5103386</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The Scottish Early Rheumatoid Arthritis (SERA) study is an inception cohort of rheumatoid (RA) and undifferentiated arthritis (UA) patients that aims to provide a contemporary description of phenotype and outcome and facilitate discovery of phenotypic and prognostic biomarkers METHODS: Demographic and clinical outcome data are collected from newly diagnosed RA/UA patients every 6 months from around Scotland. Health service utilization data is acquired from Information Services Division, NHS National Services Scotland. Plain radiographs of hands and feet are collected at baseline and 12 months. Additional samples of whole blood, plasma, serum and filtered urine are collected at baseline, 6 and 12 months RESULTS: Results are available for 1073 patients; at baseline, 76 % w</pubmed_abstract><journal>BMC musculoskeletal disorders</journal><pubmed_title>The Scottish Early Rheumatoid Arthritis (SERA) Study: an inception cohort and biobank.</pubmed_title><pmcid>PMC5103386</pmcid><funding_grant_id>ETM-40</funding_grant_id><pubmed_authors>Saunders S</pubmed_authors><pubmed_authors>Richmond R</pubmed_authors><pubmed_authors>Kumar V</pubmed_authors><pubmed_authors>Basu N</pubmed_authors><pubmed_authors>McKay ND</pubmed_authors><pubmed_authors>McLaren J</pubmed_authors><pubmed_authors>Siebert S</pubmed_authors><pubmed_authors>Wilson H</pubmed_authors><pubmed_authors>McInnes I</pubmed_authors><pubmed_authors>Tierney A</pubmed_authors><pubmed_authors>Harvie J</pubmed_authors><pubmed_authors>Baxter D</pubmed_authors><pubmed_authors>Dale J</pubmed_authors><pubmed_authors>Paterson C</pubmed_authors><pubmed_authors>Reid DM</pubmed_authors><pubmed_authors>McMahon M</pubmed_authors><pubmed_authors>Ralston SH</pubmed_authors><pubmed_authors>Porter D</pubmed_authors><pubmed_authors>Munro R</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Scottish Early Rheumatoid Arthritis (SERA) Study: an inception cohort and biobank.</name><description>&lt;h4>Background&lt;/h4>The Scottish Early Rheumatoid Arthritis (SERA) study is an inception cohort of rheumatoid (RA) and undifferentiated arthritis (UA) patients that aims to provide a contemporary description of phenotype and outcome and facilitate discovery of phenotypic and prognostic biomarkers METHODS: Demographic and clinical outcome data are collected from newly diagnosed RA/UA patients every 6 months from around Scotland. Health service utilization data is acquired from Information Services Division, NHS National Services Scotland. Plain radiographs of hands and feet are collected at baseline and 12 months. Additional samples of whole blood, plasma, serum and filtered urine are collected at baseline, 6 and 12 months RESULTS: Results are available for 1073 patients; at baseline, 76 % w</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Nov</publication><modification>2026-07-15T22:21:34.818Z</modification><creation>2026-07-09T10:20:29.334Z</creation></dates><accession>S-EPMC5103386</accession><cross_references><pubmed>27829394</pubmed><doi>10.1186/s12891-016-1318-y</doi></cross_references></HashMap>